Table 6.
Prevalence ratios of analgesics/antiepileptics/antiparkinsonians (AEP) use according to education, income, and occupation for sites in Canada, Latin America, and Albania
| Socioeconomic variables | Latin America (Natal + Manizales) | Canada (Kingston + Saint-Hyacinthe) | Albania (Tirana) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| PR | 95 % CI | P-value | PR | 95 % CI | P-value | PR | 95 % CI | P-value | ||
| Education | < Secondary | 1.36 | 0.81–2.29 | 0.247 | 1.35 | 0.62–2.94 | 0.447 | 0.78 | 0.42–1.45 | 0.440 |
| Secondary or higher | Ref. | Ref. | Ref. | |||||||
| Site 1 vs Site 2 | 3.53 | 2.28–5.47 | < 0.001 | 0.66 | 0.46–0.96 | 0.028 | ||||
| Income | Low/Medium | 1.13 | 0.66–1.95 | 0.651 | 1.64 | 1.06–2.54 | 0.025 | 1.11 | 0.75–1.66 | 0.598 |
| High | Ref. | Ref. | Ref. | |||||||
| Site 1 vs Site 2 | 3.42 | 2.20–5.31 | < 0.001 | 0.75 | 0.52–1.08 | 0.124 | ||||
| Occupation | Manual | 2.63 | 1.07–6.44 | 0.034 | 1.16 | 0.81–1.68 | 0.411 | 0.82 | 0.58–1.17 | 0.278 |
| Non-manual | Ref. | Ref. | Ref. | |||||||
| Site 1 vs Site 2 | 3.57 | 2.30–5.54 | < 0.001 | 0.68 | 0.47–0.98 | 0.037 | ||||
Controlled for site, age and sex, depression, and number of chronic illnesses, as well as comparison between grouped sites, if applicable
In Latin America, site 1 = Manizales and site 2 = Natal; In Canada, site 1 = Kingston and site 2 = Saint-Hyacinthe